Our Mission

We’re on a mission to revolutionize disease screening through noninvasive urine spectroscopy and artificial intelligence

Join Us

Awards

FIRST PLACE

Within the Association of Diagnostic and Laboratory Medicine (ADLM), we proudly secured victory in the DxPx 42PLUS1 competition, sponsored by Mayo Clinic, standing out among approximately 100 applicants.

LEAP RECIPIENT

Selected by McDermott for its groundbreaking innovation in life sciences, receiving exclusive access to world-class legal expertise and strategic resources to accelerate our growth and impact in cancer detection.

Website

Massachusetts AI Health Innovation (MAHI) Grant

Awarded by the Cambridge Innovation Center (CIC), this grant enables their expert team to collaborate with us on software development, advancing AI-powered cancer screening.

Website

Our Values

Accuracy

Strive for the highest level of accuracy and precision to ensure reliable results for patients and healthcare providers

Compassion

Show empathy and compassion for individuals undergoing screening, recognizing the sensitivity and anxiety associated with medical tests

Innovation

Foster a culture of continuous innovation, always seeking new and improved methods to enhance the accuracy and convenience of diagnostics

Integrity

Uphold the highest ethical standards in all interactions, from data privacy and patient confidentiality to business practices and research

Patient First

Prioritize the well-being, comfort, and convenience of patients, ensuring that their needs are at the forefront of all decision-making processes

Scientific Rigor

Commit to rigorous scientific methodologies, including peer-reviewed research, clinical trials, and validation studies, to ensure the reliability of diagnostic methods

Co-Founders & Leadership

Person wearing a dark gray suit jacket and white dress shirt against a light gradient background.

Matthew Laskowski

Chief Executive Officer

Leader at two high-growth tech companies

Person wearing a dark shirt against a plain background.

Dragan Sebišanović

Chief Scientific Officer

Successful exits in three diagnostic startups

Man in a suit and tie smiling, posing against a plain background.

Mark November

Chief Operating Officer

Successful exits in startups in many industries

Lisa T. Miller

Chief Commercial Officer

Founded and sold healthcare consultancy to Morgan Stanley and +$250M in healthcare sales

The Story

Over time, Dragan became disillusioned with sequencing and was in search of an alternative technology. After a +5-year diagnostic journey for an uncommon autoimmune disease, Matthew discovered an alternative data-driven approach that he would have liked to use for himself. Together, we discovered that these two puzzle pieces (Dragan’s problem and Matthew’s solution) fit together perfectly and that we shared the same goal.


We named our company Toby, after Sherlock Holmes's bloodhound.

Team

Smiling person with short hair and earrings, looking to the side.

Jackie Magno, MSM

Advisor

Operating Committee Chair and Managing Director for Golden Seeds Silicon Valley for +13 years

Scientist in lab coat and safety glasses holding a specimen container in a laboratory setting.

Wen-Yee Lee, Prof

Advisor

Research in GC-MS for +20 years and VOCs for prostate cancer detection for +6 years

Collaborators

Duke Cancer Institute

Collaborator

Collaborator for our Clinical Utility Study and Clinical Validation Study

University of South Alabama

Collaborator

Perfect demographic with interest in kidney, bladder, breast, lung, and stomach cancer

MassChallenge

Highly Ranked Acccelerator

Chosen from +1,300 applicants for the highly ranked remote and equity-free accelerator